Researchers at the National Institutes of Health discovered overactivation in multiple brain regions, including the frontal and parietal lobes and the amygdala, in unmedicated children with anxiety disorders. They also demonstrated that cognitive behavioral therapy (CBT) improved clinical s
In a rare but significant complication of cancer, the body's immune system can begin attacking the brain, resulting in rapid-onset memory loss and cognitive impairment. What precipitated this unexpected biological civil war was mostly unknown.
A new study led by UCL researchers found that menopausal women who swim in cold water on a daily basis experience considerable improvements in both physical and mental symptoms.
"Unfortunately, I've developed cold symptoms and am presently resting at home. I regret not being able to welcome the Prime Minister in person and express my best wishes for the success of all his programs," the former Karnataka chief minister said.
A new study discovered that variations in blood flow in the retina may explain why certain migraine patients have visual disturbances. The findings may provide a long-awaited visible marker for migraines that doctors may use to aid in the medical treatment of the condition.
A team from the University of Michigan, home to one of the world's largest longterm studies of people with bipolar disorder, reports their findings in the journal Psychiatry Research.
The study examined two types of internet-delivered cognitive behavioural therapy in terms of how well they lessen fibromyalgia symptoms and functional impact.
Panic attacks, which are frequent and unexpected symptoms experienced by patients with panic disorder, include overwhelming fear, sweaty palms, shortness of breath, and a rapid heartbeat. It may be possible to develop more potent treatments for panic disorder by mapping out the brain's areas
The brain's immune cells, known as microglia, have been shown to cause cognitive abnormalities following radiation exposure. As such, microglia may be a crucial target for mitigating these symptoms, according to research from the University of Rochester's Del Monte Institute for Neuroscience
Paxlovid (Nirmatrelvir-ritonavir) did not decrease the chance of developing long COVID in vaccinated, non-hospitalized patients during their initial COVID-19 infection, according to a team of UC San Francisco researchers. They also discovered a larger number of people with acute symptoms reb